Bionomics EBITDA Margin 2022-2024 | NEUP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bionomics (NEUP) over the last 10 years. The current EBITDA margin for Bionomics as of September 30, 2024 is .
| Bionomics EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
